Chinese biotech startup D3 Bio raises $200m in Series A round

Chinese biotech startup D3 Bio raises $200m in Series A round

Laboratory equipment. Photo: Pixabay

18 November, 2020

biotech D3 Bio precision medicines

Printed by Unregistered user on Sat, 16 Aug 2025 11:33:06 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese biotech firm Adagene plans $200m US IPO

Venture Capital

Chinese biotech firm RecBio raises over $227.4m in Series B round

Read more from Greater China

Chinese tech firms ride new wave of AI-powered wearables market

Bridgewater sold all its US-listed China stocks, worth $1.5b, in Q2 2025